|
|
|
|
Synergistic effects of galantamine and memantine in attenuating scopolamine-induced amnesia in mice
|
|
|
|
|
|
|
|
نویسنده
|
busquet p. ,capurro v. ,cavalli a. ,piomelli d. ,reggiani a. ,bertorelli r.
|
|
منبع
|
journal of pharmacological sciences - 2012 - دوره : 120 - شماره : 4 - صفحه:305 -309
|
|
چکیده
|
We investigated a possible drug efficacy enhancement obtained by combining inactive doses of galantamine and memantine in the scopolamine-induced amnesia model in mice. we evaluated the effects of the two drugs,either alone or in combination,using the spontaneous alternation and object recognition tasks. in both tests,combination of low doses of galantamine (0.1 mg/kg,s.c.) and memantine (0.5 mg/kg,i.p.),which were sub-active per se,rescued the memory impairment induced by scopolamine (1 mg/kg,i.p.). the results suggest that combinations of galantamine and memantine might provide a more effective treatment of memory impairments in cognitive disorders than either drug used alone. © the japanese pharmacological society.
|
|
کلیدواژه
|
Memory impairment; Multi-target; Neurodegenerative disease
|
|
آدرس
|
drug discovery and development,fondazione istituto italiano di tecnologia,via morego 30,16163 genoa, Italy, drug discovery and development,fondazione istituto italiano di tecnologia,via morego 30,16163 genoa, Italy, drug discovery and development,fondazione istituto italiano di tecnologia,via morego 30,16163 genoa,italy,department of pharmaceutical sciences,university of bologna,via belmeloro 6,40126 bologna, Italy, drug discovery and development,fondazione istituto italiano di tecnologia,via morego 30,16163 genoa,italy,departments of pharmacology and biological chemistry,university of california,irvine,ca 92697-4621, United States, drug discovery and development,fondazione istituto italiano di tecnologia,via morego 30,16163 genoa, Italy, drug discovery and development,fondazione istituto italiano di tecnologia,via morego 30,16163 genoa, Italy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|